Free shipping on all orders over $ 500

Etomoxir

Cat. No. M9048
Etomoxir Structure
Synonym:

(R)-(+)-Etomoxir

Size Price Availability Quantity
5mg USD 78  USD78 In stock
10mg USD 143  USD143 In stock
50mg USD 520  USD520 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Etomoxir is a potent inhibitor of carnitine palmitoyltransferase-I (CPT-1). Etomoxir binds irreversibly to the catalytic site of CPT-1 inhibiting its activity, but also upregulates fatty acid oxidation enzymes.

In vivo, Rats treated with Etomoxir (injected daily for 8 days at 20 mg/kg of body mass) display a 44% reduced cardiac CPT-I activity. The treatment of Lewis rats for 8 days with 20 mg/kg Etomoxir does not alter blood glucose, which is in line with comparable etomoxir-feeding studies.

Chemical Information
Molecular Weight 326.82
Formula C17H23ClO4
CAS Number 124083-20-1
Solubility (25°C) DMSO: ≥ 40 mg/mL
Storage -20°C, protect from light, sealed
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Li J, et al. Sci Rep. FFA-ROS-P53-mediated mitochondrial apoptosis contributes to reduction of osteoblastogenesis and bone mass in type 2 diabetes mellitus.

[2] Luiken JJ, et al. Biochem J. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.

Related PPAR Products
DSO-5a

DSO-5a is a potent, selective, orally active BB3 agonist.

Carfloglitazar sodium

Carfloglitazar sodium is a dual agonist of the pan peroxisome proliferator-activated receptor (PPARα/γ) with EC50 values of 1.2, 0.08, and 1.7 μM for PPARα, PPARγ, and PPARδ, respectively.It can be used in studies related to nonalcoholic steatohepatitis (NASH).

Seladelpar

Seladelpar is a potent, orally active, specific PPAR-δ agonist with an EC50 of 2 nM.

4'-O-Methylhonokiol

4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.

3-Phenyl-2-propen-1-ol

trans-Cinnamyl alcohol is a trans-isomer of Cinnamyl alcohol.

  Catalog
Abmole Inhibitor Catalog




Keywords: Etomoxir, (R)-(+)-Etomoxir supplier, PPAR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.